Brian Clevinger
InvestorFounder and Managing Director at Prolog Ventures
About
A co-founder and managing director of Prolog with over 25 years in bioscience commercialization. He previously served as CEO of vaccine developer Megan Health (1993 until its 2000 acquisition by AVANT Immunotherapeutics), led Alafi Capital's medical technology commercialization partnership A/W Company with Washington University, and held a tenured research position at Washington University; he holds a doctorate in immunology from Indiana University.
Invests in
Biotech
Deals · 2
Plastomics, Inc.Board seat
via Prolog Ventures · filed Mar 2021 · $3.5M raise
Toma BiosciencesBoard seat
via Prolog Ventures · filed Sep 2016 · $16.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
